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The DrosophilaMSL complex associates with active
genes specifically on the male X chromosome to
acetylate histone H4 at lysine 16 and increase
expression approximately 2-fold. To date, no DNA
sequence has been discovered to explain the speci-
ficity of MSL binding. We hypothesized that se-
quence-specific targeting occurs at ‘‘chromatin entry
sites,’’ but the majority of sites are sequence inde-
pendent. Here we characterize 150 potential entry
sites by ChIP-chip and ChIP-seq and discover
a GA-richMSL recognition element (MRE). The motif
is only slightly enriched on the X chromosome (2-
fold), but this is doubled when considering its prefer-
ential location within or 30 to active genes (>4-fold en-
richment). When inserted on an autosome, a newly
identified site can direct local MSL spreading to
flanking active genes. These results provide strong
evidence for both sequence-dependent and -inde-
pendent steps in MSL targeting of dosage compen-
sation to the male X chromosome.
INTRODUCTION
The occurrence of sequence motifs and their utilization appear to
be well correlated in organisms with small genomes, such as
bacteria (Wade et al., 2005). However, genomic analyses in eu-
karyotes have revealed that short sequence-specific DNA-bind-
ing motifs alone are insufficient to explain the selective occu-
pancy or specificity of regulatory factor function (Carroll et al.,
2005; Sekinger et al., 2005). Therefore, a very important question
in transcriptional regulation is how binding factors identify the
motifs at which they will function, selecting them from an excess
of sites of equal or greater predicted affinity in the genome. An
additional layer of complexity is introduced when consideringthe factors that organize chromatin into active and silent do-
mains and play a crucial role in the fidelity of gene expression
in development (Goldberg et al., 2007; Li et al., 2007; Schneider
and Grosschedl, 2007).
Dosage compensation provides a model system to study how
critical chromatin regulatory decisions are initially targeted to
genes and local chromatin domains. This is a process in which
X chromosomal genes are differentially regulated to equalize ex-
pression in males (XY) and females (XX). In the three model sys-
tems studied in depth, Drosophila, C. elegans, and mammals,
this occurs through sex-specific, X-specific targeting of chroma-
tin regulatory complexes (Lucchesi et al., 2005).
The signal for X chromosome targeting is most clearly under-
stood in mammals, where one of the female X chromosomes is
inactivated and acquires characteristics of silenced heterochro-
matin. In X inactivation, expression of the noncoding Xist RNA
appears to be necessary and sufficient to initiate the process
of silencing a chromosome in cis (Lee et al., 1996; Herzing
et al., 1997; Wutz and Jaenisch, 2000). Xist RNA associates
with the chromosome that encodes it (Clemson et al., 1996),
and this is linked to the silencing event (Okamoto et al., 2004).
Additional X chromosome sequences might play a role as
‘‘boosters’’ for spreading of Xist RNA (Lyon, 2003), but auto-
somes can be at least partially inactivated if expressing Xist
RNA in early development (Lee and Jaenisch, 1997), suggesting
that X-specific booster sequences are not obligatory.
In C. elegans, the dosage compensation complex (DCC)
downregulates genes on both hermaphrodite X chromosomes
by approximately half to achieve dosage compensation (Luc-
chesi et al., 2005). In this model system, there is evidence for
hundreds of autonomous recognition sites along the length of
the X chromosomes that contribute to targeting (Csankovszki
et al., 2004). Recently, specific DNA sequences have been cor-
related with this function (McDonel et al., 2006) and found in lo-
cations of high DCC occupancy by ChIP-chip (Ercan et al., 2007).
Although these sequences are only enriched 1.25- to 1.5-fold
on X, nonrandom clustering may explain how the X chromosome
is initially identified (McDonel et al., 2006; Ercan et al., 2007).Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc. 599
A second step of sequence-independent spreading has been
postulated to explain the full pattern of X chromosome binding
(Csankovszki et al., 2004), but characterized recognition sites
have not yet been shown to possess this ability when moved
to autosomes.
In Drosophila, the MSL complex upregulates X-linked genes in
males by approximately 2-fold to achieve dosage compensation
(Lucchesi et al., 2005). No DNA sequence motif uniquely iden-
tifies the X chromosome, although X chromosomes throughout
the Drosophila genus show enrichment for simple sequence re-
peats when compared to autosomes (Stenberg et al., 2005; Gal-
lach et al., 2007). Although the MSL-binding pattern on the X
chromosome has been mapped at high resolution by ChIP-
chip, no sequence within the binding sites has been identified
to account for the striking X chromosome specificity (Alek-
seyenko et al., 2006; Gilfillan et al., 2006; Legube et al., 2006).
MSL complex binds broadly within the bodies of active X-linked
genes, with a 30 bias (Alekseyenko et al., 2006; Gilfillan et al.,
2006). Reminiscent of mammals, there are at least two noncod-
ing RNAs that participate in dosage compensation in Drosophila
and are encoded by the X chromosome (Amrein and Axel, 1997;
Meller et al., 1997). These roX RNAs act like nucleation sites for
MSL spreading when ectopically expressed from autosomes,
suggesting that they, like Xist, are autonomous targeting ele-
ments (Kelley et al., 1999; Park et al., 2002). However, unlike
Xist, roX RNAs expressed from other chromosomes can still rec-
ognize a roX mutant X chromosome in trans, suggesting that
there are additional characteristics that distinguish the X chro-
mosome from the autosomes (Meller et al., 1997; Park et al.,
2002).
One model is that the subset of MSL-binding sites that remain
in the absence of either the MSL3 chromodomain protein, the
MLE helicase, or the MOF acetyltransferase defines the set of
core MSL1/MSL2 initiation sites, and that the majority of sites
are recognized in a second, sequence-independent step in cis
(Kelley et al., 1999; Larschan et al., 2007). Cytologically, there
are30–70 sites seen on polytene chromosomes inmsl3mutant
males (Palmer et al., 1994; Demakova et al., 2003). However, the
existence of this limited set of sites has not been sufficient to ex-
plain the apparently autonomous recognition of many X-linked
genes in translocation and transposition stocks (Fagegaltier
and Baker, 2004; Oh et al., 2004). This has led to an alternative
model in which degenerate sequences define all sites on the X
chromosome, with a hierarchical recognition mechanism. How-
ever, in this case the sequences have been degenerate enough
to confound definition (Dahlsveen et al., 2006; Gilfillan et al.,
2006, 2007; Kind and Akhtar, 2007).
Here we use chromatin immunoprecipitation followed by mi-
croarray (ChIP-chip) or sequencing (ChIP-seq) to identify a large
set of candidate chromatin entry sites (CES) in order to test the
two-step model for MSL binding. These sites are proposed to
be recognized in a sequence-dependent manner, and indeed
we found a GA- or TC-rich motif common to the majority of sites.
Mutagenesis studies reveal the importance of this motif for MSL
recognition in a cell culture reporter assay and when placed on
autosomes. Interestingly, a newly identified site can direct local
MSL spreading to flanking active genes on an autosome, sup-
porting its proposed activity as a CES. These results provide600 Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc.strong evidence for both sequence-dependent and -indepen-
dent steps in the model for MSL targeting of dosage compensa-
tion and provide a general framework for the identification of ini-
tiation sites for other chromatin regulators that function broadly
over chromatin domains.
RESULTS
MSL3-Independent High-Affinity Sites Represent
a Subset of the Wild-Type Binding Pattern and Are
Predominantly Located within Genes
We previously proposed that the incomplete MSL-binding pat-
tern seen on polytene chromosomes in the absence of MSL3
might represent specific initiation or chromatin entry sites for
MSL complex recognition of the X (Kelley et al., 1999). To test
this hypothesis, we combined genetic analysis with ChIP-chip.
We chose to analyze msl3 mutant embryos to avoid potential
complications from working with dying male larvae. Construction
of a genetic stock in which all male embryos were msl3 mutant
was accomplished by crossing msl3 mutant males carrying an
msl3+ transgene on their X chromosome tomsl3mutant females.
All sons from such a cross are msl3 mutant, while all daughters
receive the msl3+ transgene. Females, however, do not express
MSL2 (Lucchesi et al., 2005), so MSL2 ChIP of the population
results in analysis of only the male embryos. We performed
two independent biological replicates of the ChIP-chip experi-
ment (Figure 1), calculated mean values for each probe on the
microarrays, and then determined significant clusters of binding
on the X and the autosomes.
As expected, our positive clusters were highly enriched on the
X chromosome. Using the relative enrichment on the X
compared to an autosome, we determined that there were at
least 150 sites on the X (and 5 sites on 2L, the autosome repre-
sented on the array). There are no absolute criteria for setting the
parameters that determine the number of sites; however, this
was a reasonable compromise between the enrichment on the
X and coverage. One hundred and fifty is a higher number of
MSL3-independent sites than originally predicted based on im-
munostaining of msl3 mutant polytene chromosomes. However,
we recently demonstrated that banding patterns on polytenes do
not provide single site resolution and thus can lead to both un-
derestimation of the number of individual binding sites as well
as an inability to distinguish relatively large changes in binding
site occupancy (Larschan et al., 2007). We named the sites
CES followed by their cytological position, based on the polytene
chromosome map (e.g., CES11D1) (Table S1 available online).
Among the 150 sites, we recovered roX1, roX2, and 18D11, pre-
viously identified as MSL3-independent sites in our lab (Kelley
et al., 1999; Oh et al., 2004), as well as DBF3 (CES3A8), DBF7
(CES10F2), DBF9 (CES18D3), and DBF12 (CES1B14), previously
characterized as high-affinity sites by P. Becker and colleagues
(Dahlsveen et al., 2006).
Next we asked whether these 150 candidate chromatin entry
sites were a subset of wild-type MSL targets. On average, the
clusters observed in our CES ChIP-chip experiments were ap-
proximately 1.5 kb in size, and virtually all (98%) were contained
within the full set of sites in wild-type. Consistent with this obser-
vation, we found that CES overlap with genes (135 of 150).
Figure 1. MSL3-Independent Chromatin Entry Sites Are a Subset of the Wild-Type Binding Pattern for MSL Complex and Coincide with the
Strongest Enrichment Peaks Detected by ChIP-seq
Two representative chromatin entry sites, CES11D1 (A) and CES15A8 (B), are shown. ChIP-chip profiles were generated from y w; MSL3-TAP; msl3 embryonic
chromatin (WT) using IgG to IP the TAP epitope, or msl3 mutant embryos (CES) using anti-MSL2 antibodies. DNA resulting from ChIP was hybridized to custom
NimbleGen tiling arrays (Alekseyenko et al., 2006). The y axis shows the log2 ratio of IP/Input signal. The ChIP-seq tag profile (Solexa) was obtained from an MSL3-
TAP transformed male cell line, Clone 8, using IgG to IP the TAP epitope. The ChIP-seq profile displays broad distribution along WT MSL targets and high peaks
that correspond to entry sites. The y axis shows the tag density. Gray lines within ChIP-chip and ChIP-seq panels indicate the regions identified as bound clusters
(See Experimental Procedures for details). Genes are color-coded based on their transcriptional status (transcribed, red; nontranscribed, black; genes that are
differentially transcribed in S2 and Clone 8 cells, salmon; and genes without transcriptional data, gray). Genes on the top row are transcribed left to right, and
genes on the bottom row are transcribed from right to left. Numbers along the x axis refer to chromosomal position (bp) (Dm1 release coordinates). Polytene
map cytological locations are indicated below.ChIP-seq of the Wild-Type MSL Pattern Detects Strong
Peaks of Binding within CES Candidates
Concurrent with the ChIP-chip analysis of msl3 mutants, we per-
formed Solexa sequencing of MSL3-TAP ChIP from male tissue
culture cells. We were testing whether this nonarray and nonhy-
bridization-based approach would yield similar or higher-resolu-
tion results for wild-type MSL3 binding. When we profiled wild-
type MSL3-TAP in Clone 8 cells, we were able to observe the
broad binding patterns covering active genes on the X previously
seen in ChIP-chip analysis (Alekseyenko et al., 2006), with 91%
of the positive genes in ChIP-seq overlapping with 89% of bound
genes in our previous ChIP-chip data set. Using ChIP-seq we
found 619 binding sites on X and only 2 on 2L (our negative con-
trol), demonstrating the high quality of the experiment. Notably,
we also discovered a set of sharp peaks extending far above the
broadly bound regions, which were not evident in ChIP-chip
analysis. These peaks are of such striking amplitude that when
plotted in Figure 1, the broad and significant signal of overall
binding surrounding them is not readily evident at this scale
(see gray bars that indicate significant signal). Furthermore,
there was a remarkable coincidence of the ChIP-seq peaks
from MSL3-TAP in wild-type with our newly identified chromatin
entry sites found genetically, with 91% inclusion of the 150 entry
sites in the top 309 Solexa peaks (see Figure S2D and Experi-
mental Procedures for details). The set of top peaks covering
the entry sites also were distinguished by their magnitude(Figure S2E), therefore we used the top 309 peaks for further
analysis.
To determine whether or not a bias for recovery of these frag-
ments was intrinsic to the general chromatin composition of
those regions rather than being a consequence of the specific
ChIP experiments, we sequenced sonicated and amplified input
DNA. We found that any intrinsic biases in the input could not
account for the sharp peaks observed after MSL pulldown and
recovery (data not shown).
To determine whether the peaks were somehow enhanced by
the ChIP-seq technique, or quenched in ChIP-chip analysis, we
assayed MSL3-TAP chromatin IP samples directly by QPCR for
regions encompassing the ChIP-seq peaks. We found an excel-
lent correlation between fold differences seen by QPCR and
those measured by ChIP-seq around 3 of 3 peaks analyzed
(Figure S1). We conclude that the key difference between the
ChIP-seq and ChIP-chip platforms appears to be in the dynamic
range that can be measured. Several studies have reported
a general agreement between the two platforms (Euskirchen
et al., 2007; Mikkelsen et al., 2007; Boyle et al., 2008), but those
comparisons were mostly based on visual inspection rather than
a statistical comparison. Also, if the methods are compared for
transcription factor binding, which typically occurs in sharp
peaks, the differences would not be so apparent. However, the
MSL complex binds quite broadly over transcription units, and
before the ChIP-seq analysis, it was less evident that thereCell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc. 601
Figure 2. A GA-Rich Motif Is a Common Feature in MSL Chromatin Entry Sites
(A) Identification of the MRE motif enriched in CES. The motif logo is shown with representative examples below. This motif occurs once in CES11D1 and three
times in CES5C2. The GA-rich core is highlighted in red. We are arbitrarily showing the GA- rather than the TC-rich strand. This motif was identified using the
chromatin entry sites as determined by the ChIP-chip data; a nearly identical motif is obtained from the WT Solexa data (Figure S2).
(B) Solexa peaks center on the MRE motif in chromatin entry sites. Shown is a heatmap of Solexa profiles (tag densities increase from red to white), aligned by the
MRE motif in each of the 137 individual CES that contain the motif. In nearly all cases, the location of the sharp peaks coincides with the motif location.
(C) The MRE motif tends to localize to the center of strong Solexa peaks. The top 500 Solexa peaks were ranked by height on the x axis and then MRE motifs within
a 2 kb window flanking each peak were mapped on the y axis. Some peaks contain multiple motifs; to avoid showing the same region twice, only the strongest
peaks in any 3 kb region were considered. Most motifs map near the center, but motif centering decreases as peak intensity weakens.
(D) The MRE motif is enriched on the X chromosome, compared to autosomes. Motif frequency for each chromosome was normalized to its frequency on all
autosomes. Colors correspond to different thresholds for defining the occurrence of the motif. At all thresholds, the motif is enriched on the X. As the stringency
increases, the enrichment increases but a smaller number of motifs are identified.were strong quantitative differences within the broad binding
profiles. For MSL complex binding, ChIP-seq clearly reveals
a subpattern of high-affinity sites within the wild-type binding
pattern. The strong coincidence of the peaks of wild-type
MSL3-TAP binding detected by ChIP-seq with the subset of
sites of MSL2 binding in msl3 mutants provides strong evidence
that this subset of MSL-binding sites may have a significant bio-
logical role.
Discovery of a Sequence Motif in Entry Sites and ChIP-
seq Peaks that Is Enriched on the X Chromosome
Encouraged by the strong correlation between ChIP-seq and
ChIP-chip results, we used MEME (Bailey et al., 2006), a robust
searching algorithm, to analyze the 150 candidate entry sites and
the top 309 ChIP-seq peaks for a sequence motif. We found the
same highly significant 21 bp sequence centered around a core
GAGA (or TCTC) repeat using both data sets (Figures 2A and S2).
This sequence is compatible with the conserved MSL-binding
motif we previously identified by direct comparison of the roX1602 Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc.and roX2 genes from multiple species (Park et al., 2003) and
the high-affinity sequences characterized by Gilfillan et al.
(2007). Other motif searching algorithms including WEEDER,
and MDscan (Liu et al., 2002; Pavesi et al., 2004), gave a very
similar but shorter top motif. We note that while the chromatin
entry sites form a subset of the wild-type sites, previous at-
tempts to recover a motif from wild-type data failed because of
the excess of extraneous DNA sequences included in those re-
gions. For convenience we will refer to our newly discovered
motif as the ‘‘MSL recognition element’’ (MRE). Interestingly,
the MRE includes the GAGA factor (GAF) consensus sequence
GAGAGA, but to date significant coincidence of MSL and GAF
binding has not been evident (Sun et al., 2003; van Steensel
et al., 2003). Similarly, we wondered whether a CT-rich logo
might indicate involvement of CTCF, named initially for its affinity
for CT-rich sequences (Lobanenkov et al., 1990). However, the
logo discovered for Drosophila CTCF from ChIP-chip studies
of the Adh and Bx-C regions bears no resemblance to our GA
motif (Holohan et al., 2007).
In Figure 2B, we display a heatmap of the ChIP-seq profiles
around the chromatin entry sites containing MREs. Strikingly,
in nearly all cases the sharp wild-type ChIP-seq peaks are cen-
tered on the MRE within the CES, with a rapid decrease away
from the motif. To determine the relationship between the peaks
and the occurrence of MREs, we ordered the ChIP-seq peaks by
their height and plotted all the motifs (p value < 105) in the neigh-
borhood (1 kb in each direction) (Figure 2C). Clearly, MREs are
concentrated at the center of the strongest peaks; they are
more dispersed as the peaks get weaker. If we are to base the
likelihood of a peak being a CES on the clustering of MREs within
the peak, the estimate of 150 chromatin entry sites appears to be
somewhat conservative. But beyond 300, the alignment de-
generates, suggesting that weaker peaks are not dependent
on MREs.
A motif utilized for X-specific MSL binding on the X ideally
should be enriched on X. Therefore, we surveyed the D. mela-
nogaster genome for the occurrence of potential MREs on X
and autosomes. We found that the motif was approximately 2-
fold enriched on X versus autosomes for a wide range of thresh-
olds for defining a sequence match (see Figure 2D). At a p value
of 105, there are 3652 and 8770 motifs on the X and autosomes,
respectively, for an enrichment of 1.8-fold in terms of motif
density (167.7 copies/Mb on X versus 92.3 copies/Mb on auto-
somes). At this stringency, 137 of the 150 candidate entry sites
Figure 3. Test for CES Function in a Luciferase Reporter Assay
(A) Experimental design and structure of the constructs used for a dual Firefly/
Renilla luciferase reporter assay. S2 cells cotransfected with the Firefly lucifer-
ase construct containing each 1.5 kb CES fragment and the control Renilla
luciferase plasmid were treated with dsRNA against either GFP (control) or
MSL2 (experimental).
(B) Examples of Firefly/Renilla luciferase activity conferred by nine chromatin
entry sites normalized to the value obtained after msl2 RNAi. CES18D11 is
a rare example of a CES that failed to show MSL2-dependent upregulation
in this assay. Error bars represent standard deviations based on four repli-
cates.contain an MRE (91%), with 51 having 2 or more MREs within
500 bp (34%).
The genome sequences of twelve Drosophila species became
available recently, and it has been of considerable interest to de-
termine how appropriate dosage compensation evolved follow-
ing sex chromosome translocation events in the various species.
We found that the MRE discovered in D. melanogaster was sim-
ilarly enriched on the X chromosomes of other sequenced spe-
cies. Figure S2 shows results for two species (D. simulans and
D. yakuba).
We define chromatin entry sites functionally, as the binding
sites for partial MSL complex in the absence of MSL3. In con-
trast, the MRE is a consensus sequence that is important within
CES but clearly is found elsewhere in the genome. The simple
presence of an MRE is not sufficient to predict MSL binding,
as autosomes carry thousands of matches that are not bound.
In addition, among 3652 predicted MREs on X, only 6% (224/
3652) are located within the 150 selected entry sites. At this
threshold, 91% of the entry sites have motifs, but many motifs
are ignored. Therefore, we continued our analysis on two fronts,
first asking whether the MRE sequence is implicated functionally
in MSL binding and second, identifying additional parameters
that would better define the motifs that are actually chosen on X.
Functional Analysis of the MRE within Candidate Entry
Sites with a Luciferase Reporter Assay
To determine whether the MRE is important for MSL recognition
at the newly identified sites, and whether it can function when
removed from its normal chromosomal context, we employed
a luciferase-based reporter assay in male S2 tissue culture cells.
The luciferase assay (Figure 3) is based on the observation that
MSL binding downstream of the major roX2 transcription unit
positively regulates expression of roX2 (Bai et al., 2004). The
MSL-binding site in roX2 displays DNase hypersensitivity and
thus has been called the roX2 DHS (Kageyama et al., 2001).
We constructed a plasmid containing the roX2 promoter region
and the roX2 DHS, with the intervening roX2 transcription unit
replaced by the Firefly luciferase gene (Figure 3A). Upon trans-
fection into S2 cells, the activity of the Firefly luciferase is highly
dependent on the presence of MSL complex, as activity is de-
pressed 7-fold by RNAi treatment for MSL2 (Figure 3B). The
DHS region is required to confer MSL dependence to the re-
porter gene. To provide accurate quantitation of reporter gene
activity, we used a dual luciferase system in which normalization
was conducted using a control plasmid that contains the Renilla
luciferase gene fused to an MSL-independent promoter. The
Firefly and Renilla luciferase reporter genes are quantitatively
assayed using independent substrates.
We found that 1.5 kb wild-type DNA segments containing can-
didate entry sites gave a clear response in the reporter assay
(Figure 3 and Table S2). We tested 29 of the 150 candidate
MSL-binding sites in the luciferase assay, and 21 of these re-
sponded positively (Table S2 and data not shown). To exclude
roX2 promoter-specific effects, we cloned three different auto-
somal promoters upstream of the luciferase gene. Derivatives
of these constructs carrying various CES also demonstrated de-
pendency on MSL2, similar to the activity observed with the roX2
promoter. Interestingly, the effect inversely correlated with theCell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc. 603
absolute promoter strength (Table S2). Next we performed dele-
tion and mutational analysis to test whether or not key residues in
the MRE were necessary for the observed MSL-dependent
transcriptional response.
We initially narrowed down the 1.5 kb positive fragments for
five putative entry sites to 500 bp, and in four cases the positive
activity tracked unambiguously with the mapped MREs (Figures
4 and S3 and Table S2). In subsequent deletion analyses, we
were able to identify a 150 bp fragment of CES5C2 with three
MREs that retained function, but a 150 bp subclone of
CES11D1, with one MRE, did not (Figures 4 and S3). We created
point mutants in the CES5C2 (150 bp) and CES11D1 (500 bp)
fragments to examine the requirement for core residues (Figures
4 and S3). We found that the MREs were absolutely required for
reporter gene activity in all cases and combinations. In order to
further ask whether the MREs were not only necessary but might
also be sufficient in this context, we retained the motif location
but randomized the rest of the surrounding sequence, keeping
the GC content constant. Surprisingly, we found that for
CES5C2, such randomized fragments were still functional, dem-
onstrating that the central sequence motif plays the primary role
in MSL recognition and function. These results (Figure 4) provide
strong evidence for the importance of key residues in the MRE.
Transgenic Entry Sites Attract MSL Complex
to Autosomes and Are MSL3 Independent
Based on the results of the sequence motif analysis and the func-
tional luciferase assays, we proceeded to in vivo cytological and
ChIP analyses of five candidates: CES11D1 (one motif), CES1C4
(one motif), CES9A3 (two motifs), CES5C2 (three motifs), and
CES18D11 (one motif). Of these, all were positive in the lucifer-
ase assay except CES18D11, which was chosen for further anal-
Figure 4. The MRE Motif Is Required for MSL Complex
Binding to CES
Structure of the DNA fragments tested in the context of CES11D1 (A)
and CES5C2 (B) and the activities they display in the luciferase assay
in S2 cells and when inserted in a specific location (37B7) on chromo-
some 2L in transgenic flies (MSL2 ChIP). Numerical values in red were
scored positive, black were negative, and blue were considered inter-
mediate. Positions of the motifs are shown as red boxes; when
mutated, MRE motifs are shown as non-red boxes (please refer to
Figure S3 for sequence changes within the motif). Randomized DNA
sequences in the shortest subclones not affecting the MRE motifs
are shown in purple or dark blue (with only the motif core remaining in-
tact). Luciferase and ChIP data are based on at least three indepen-
dent experiments. n/d, not determined.
ysis because of previous cytological and ChIP data
supporting its MSL-binding capacity (Oh et al., 2004).
We inserted these candidate chromatin entry sites and
their subclones into two different genomic positions on
chromosome 2 by site-specific recombination. Following
replacement of a mini-white gene cassette, we deter-
mined that each insertion had occurred at the correct
position in the genome by PCR. We inserted the roX1
DHS as a positive control and a GFP gene as a negative
control.
We assayed our initial transgenic insertion lines at the level of
polytene chromosome staining. We asked whether or not a new
MSL3-independent binding site was created in polytene chro-
mosomes by immunostaining for MSL2 in an msl3 mutant back-
ground. For this, we used females ectopically expressing MSL2
but homozygous mutant for msl3. The candidates with MREs
demonstrated positive signals in all cases (Figures 5, S4, and
S5). On average, the CES candidates integrated at 37B7 dis-
played better ability to recruit MSL complex than when inserted
in 53F8 (Table S3). This result confirmed that the isolated sites
were MSL3 independent and thus fit our criteria for their initial
identification. Our immunostaining results were generally in
agreement with the luciferase data. Interestingly though, the
CES18D clone that failed to upregulate the luciferase reporter
displayed consistent binding in our immunostaining assay (Table
S3 and Figure S5), with improved detection compared to our
previous work (Oh et al., 2004).
The MRE Motif Is Necessary for MSL Complex Binding
to Entry Sites In Vivo
Does MSL binding within entry sites always follow the MRE? To
address this question we used directed ChIP analysis as a high-
resolution alternative to conventional cytological analysis. We
used a mixed population of embryos in which all individuals
carried one copy of the transgene insertion, but only 50% (the
males) would be expected to form the MSL complex. We de-
signed primers specific for the hybrid attL flanking sites common
to all insertions to create a ChIP assay in which individual strains
could be treated identically following chromatin isolation. Fol-
lowing crosslinking, IP with anti-MSL2, isolation of DNA, and
analysis by QPCR, we found that 0.5–1.5 kb segments of
CES5C2 and CES11D1 were positive in all assays and could604 Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc.
be subdivided into positive and negative subclones (e.g.,
CES5C2–6 versus CES5C2–4) based on the presence or the ab-
sence of the MRE (Figure S3). Indeed, all the subfragments en-
compassing MREs recruited MSL complex to the autosomal
integration site and were bound by MSL2, as assayed by ChIP
(Figure 4).
Next we tested the same sequences and mutations for
CES11D1 and CES5C2 that were tested in the luciferase assay.
These fragments contained one (CES11D1) or three (CES5C2)
MREs. Three-nucleotide substitution in the core of the single
Figure 5. MSL Complex Is Recruited to Entry Sites Placed on Auto-
somes
Polytene chromosomes from homozygous CES-X{37B7}; H83M2-6I, msl3 fe-
males were immunostained with anti-MSL1 antibodies. (A) roX1 DHS (300 bp).
(B) CES11D1 (1.5 kb). (C) CES9A3 (1.5 kb). (D) CES5C2 (1.5 kb). (E) CES5C2-6
(268 bp, containing three motifs). (F) CES5C2-4 (268 bp, lacking a motif). White
arrows point to the positive signals at the integration sites, and a green arrow
points to the cytological location with no visible staining. The X chromosome in
each nucleus displays the partial pattern typical of msl3 mutants.motif in the positive subclone CES11D1-2 completely abolished
MSL binding. When we decreased the subclone size to 150 bp
(CES11D1-150) and the motif was present, we observed reduced
but significant binding. This demonstrates that the ChIP assay
was more sensitive than the luciferase assay, possibly because
it is directly measuring binding rather than asking for transcrip-
tional upregulation as a consequence of binding. In this mini-
mized system, we randomized the DNA sequence, keeping the
GC content and position of the MRE constant. Surprisingly, this
new altered sequence (CES11D1-scr150) displayed pronounced
binding similar to the original DNA, indicating that the MRE is
sufficient for MSL recruitment at this ectopic location, without
multimerization (Figure 4). Additional confirmation of the impor-
tance of the MRE came from subfragments of CES5C2, which
carries three motifs. First we found that mutation of individual
MREs reduced binding to varying degrees (Figure 4). Second, si-
multaneous mutation of two MREs completely abolished recruit-
ment of the complex. Interestingly, the smallest fragment tested
(CES5C2-150) carrying all three intact MREs displayed binding
very similar to larger subclones. We subsequently asked whether
it is the whole motif (21 bp) or just its central part (15 bp) that is
needed for complex binding. To answer this question we created
two different randomized sequences. In one case, scrambling
affected all sequences except the three 25 bp segments contain-
ing the motifs (CES5C2-scrSY), whereas in CES5C2-scrArt, only
the 15 bp core sequences in these motifs remained unaltered.
Spacing between the motifs and the GC content were kept con-
stant. We detected weak residual binding in CES5C2-scrArt, but
CES5C2-scrSY showed binding that exceeded the original frag-
ment. These results suggest that integrity of the full MREs in this
entry site are essential for binding (Figure 4) with no evidence for
a requirement for local flanking sequences.
If MREs are both necessary and sufficient for binding in the
two cases tested, why does the MSL complex bind some
MRE-containing sites but skip many others? This is not a novel
problem in genomics, as predicted sites for sequence-specific
binding factors often greatly exceed the number of sites actually
utilized. Increasing the stringency with which we call a motif
a match did not improve our ability to predict entry sites on the
Figure 6. Histone H3 Is Depleted overMREs inChromatin Entry Sites
Average H3 profile centered over the best MRE within 137 CES (black) shows
clear depletion. In contrast, the best (green) or a random set (blue) of 137 MRE
motifs outside CES display a relatively flat profile. The histone occupancy data
are from S2 and Clone 8 cells (Larschan et al., 2007).Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc. 605
X chromosome (Figure S2). These results suggest that one or
more additional characteristics guide the MSL complex to spe-
cific sites on the X. Therefore, we searched for secondary
sequence motifs that might contribute to the specificity of the
MRE. However, all additional motifs lacked predictive value, as
they were no more enriched in CES than they were in the entire
X chromosome (data not shown).
A logical aspect of recognition could be relative accessibility of
the MRE within its chromatin environment. For example, func-
tional MREs might be located in a particular position with respect
to nucleosomes or reside in relatively depleted regions. There-
fore, we analyzed histone H3 occupancy over the entry sites.
We determined the average H3 signal after aligning the 150 entry
sites by their best motifs and found a clear H3 depletion centered
over these sites (Figure 6 and data from Larschan et al., 2007).
This averaged profile was not observed over the remaining,
unselected motifs on X (Figure 6). These results suggest that
nucleosome depletion might be a key defining characteristic of
functional chromatin entry sites.
We further examined the enrichment of MREs within active
genes. Requiring MREs to be coincident with H3K36me3, a chro-
matin mark in the bodies of active genes, reduces the number of
potential sites from 3652 to 449 on X and from 1977 to 105 on 2L.
The enrichment on the X compared to 2L therefore increases
Figure 7. MSL Complex Spreads into Neighboring
Genes from CES5C2 Inserted on an Autosome
(A) MSL3-TAP ChIP in the region surrounding the 37B7 inte-
gration site where either GFP (1.9 kb), CES5C2-4 (258
bp, no MREs), or CES5C2-6 (268 bp, three MREs) are placed
(y w; CES-X{37B7}/ MSL3-TAP; H83M2-6I, msl3 mixed sex
embryos). Top panel: genetic map and location of probes;
Dm3 release coordinates are shown. Bottom panel: MSL3-
TAP data for GFP (green), CES5C2-4 (blue), and CES5C2-6
(red) indicate that only CES5C2-6 effectively targets the MSL
complex and directs limited spreading to neighboring genes.
Error bars represent standard deviations based on three rep-
licates.
(B) Two-step model for MSL targeting of the X chromosome.
X, X chromosome, A, autosome. First step: MSL complex tar-
gets >150 chromatin entry sites containing MRE motifs on the
X chromosome. The autosome is normally ignored, unless
a CES from the X is inserted on the autosome. Second step:
Local spreading from entry sites leads to MSL binding to the
majority of active genes on the X chromosome. In addition,
an ectopic CES can lead to targeting of flanking active genes
on an autosome, as seen in the results displayed in (A).
from 1.8 to 4.3 when H3K36me3 is considered. Fur-
thermore, the proportion of motifs on the X that fall
within our data set of 150 CES is 6% overall (224/
3652), but when only the motifs in the H3K36me3-
positive regions are considered, the proportion of
motifs that belong to CES increases to 30%
(133/449). This is encouraging, as we believe that
150 is likely to be a conservative estimate for the
actual number of functional CES. Furthermore,
122 of the 150 candidate CES are retained under
these criteria, strongly suggesting that additional
identifying characteristics correlate with active gene expression.
These results suggest that chromatin context could play a key
role in selection of potential sites, and that our predictive power
will improve as we learn more about the rules that govern the
organization of complex genomes.
High-Affinity Sites Inserted on Autosomes Direct MSL
Spreading to Flanking Expressed Genes
The two-step model for MSL binding to the X chromosome in
Drosophila males proposes that after an initial, sequence-spe-
cific recognition step, the complex spreads in cis to active genes
to achieve its complete pattern. We found that candidate entry
sites inserted on chromosome 2L did not show spreading at
the level of polytene chromosome staining. However, we re-
cently observed that polytene chromosome analysis cannot
distinguish whether or not individual genes within clusters are
bound or not. Therefore, to ask whether entry sites might cause
MSL binding to occur in flanking autosomal chromatin, we per-
formed ChIP analysis of the local area surrounding the attP inser-
tion site in transgenics carrying the GFP, CES5C2-4, and
CES5C2-6 insertions. We probed the region up to 20 kb distant
from the insertion site, testing locations in flanking active and in-
active genes. We found that GFP and CES5C2-4 (lacking MREs)
showed no MSL binding above background at any of the flanking606 Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc.
regions tested, but that CES5C2-6 (containing three MREs)
showed significant binding at specific locations (Figures 7A
and S6). Interestingly, these locations correlated with the 30
ends of active genes. A signal at flanking regions could be due
to IP of larger than expected chromatin fragments. However,
this was clearly not the case when considering the Nak gene.
Probes near the 50 end of Nak gave no significant signal, even
though they were located between the transgene insertion site
and the strongly bound 30 end of the active gene. Together, these
results demonstrate that entry sites removed from the X chromo-
some have the ability to cause MSL binding in flanking chromatin
on autosomes. These results strongly support both sequence-
dependent and sequence-independent steps in MSL binding.
DISCUSSION
We previously proposed that MSL targeting of the X chromo-
some occurs in at least two steps (Figure 7B). In the first step,
roX genes and other chromatin entry sites attract the complex
to the X chromosome (Kelley et al., 1999). In the second step,
MSL complex spreads from entry sites to genes in flanking chro-
matin by recognizing chromatin marks indicative of active tran-
scription (Larschan et al., 2007). The mechanism governing the
first step in MSL recognition of the X chromosome had remained
elusive. The isolation of a large set of potential chromatin entry
sites by ChIP-chip and ChIP-seq has allowed us to identify com-
mon features of these sites.
Our studies have revealed that they are enriched for a GA (or
TC) repeat sequence, and that mutagenesis of this sequence
leads to loss of autonomous MSL binding to individual sites.
Our findings have several important implications. First, we sug-
gest that there are more MSL entry sites than originally proposed
from the analysis of MSL binding to polytene chromosomes in
msl3 mutants. Based on ChIP-chip of msl3 mutant embryos us-
ing anti-MSL2, there are at least 150 sites. Furthermore, the strik-
ing correlation of these sites with strong peaks of wild-type MSL
binding using ChIP-seq suggests that the number could ap-
proach 300. This is important, as previous studies that appeared
to refute the entry site model found apparently autonomous
binding of X chromosome genes lacking mapped sites (Fage-
galtier and Baker, 2004; Oh et al., 2004). The existence of
many more entry sites than were detected at the cytological level
could, perhaps, explain this finding.
Interestingly, the X chromosome and autosomes of D. mel-
anogaster and six other species were compared recently for
the prevalence of all sequence words up to 13 nt long (Gal-
lach et al., 2007). From this work it is clear that X chromo-
somes have evolved to be enriched for certain types of sim-
ple sequences including GA-rich repeats, which we implicate
here in dosage compensation. However, additional parame-
ters must be used to help restrict the recognition of many
GA repeats, such as nucleosome depletion to leave these
sites relatively open for binding, and colocalization within ac-
tive gene clusters. We provide correlative evidence for these
parameters and eagerly await additional insights as the Dro-
sophila genome becomes increasingly tractable for analysis
at the level of local physical properties and higher-order inter-
actions.Importantly, the question of recognition site specificity of tran-
scription factors in general faces a similar, as yet unsolved prob-
lem in metazoans. Of the many sites predicted to be favored by
individual factors, how is it that only a small fraction of these are
actually occupied? The fidelity of sequence motifs itself is clearly
not sufficient to answer this question, and organization relative to
genes, other binding factors, positioned nucleosomes, and
three-dimensional (3D) location within the nucleus are all factors
under investigation.
A second implication of our finding that chromatin entry
sites are more numerous than previously expected is that
spreading of MSL complex on the X chromosome may nor-
mally be quite modest. In particular, it is an appealing idea
that entry sites are identified in part because of their location
within expressed gene clusters and may not usually need to
spread beyond such clusters (10–30 kb). This would explain
why spreading from candidate entry sites is rarely seen at the
cytological level and requires ChIP for detection. Furthermore,
this could explain previous cytological data, in which MSL
spreading does not appear to extend into autosomes in X:A
translocations (Fagegaltier and Baker, 2004; Oh et al., 2004).
Alternatively, it is possible that spreading is normally quite ro-
bust on X but relies on the close proximity and 3D organiza-
tion of other entry sites and roX genes. These conditions can-
not be duplicated when individual chromatin entry sites are
placed in ectopic locations for analysis. The next big step in
addressing these possibilities will be to transpose large con-
structs, containing entry sites in combination with roX trans-
genes, to the autosomes.
Finally, our results suggest that the use of ChIP-seq technol-
ogy may greatly enhance the ability to identify potential initiation
sites for other chromatin-organizing complexes that act broadly
on large genomes. The dynamic range measurable by ChIP-seq
could prove to be a powerful tool for deciphering the currently




A 359 bp fragment from the roX2 gene promoter (Bai et al., 2004) was cloned
into the pGL3-Basic vector (Promega) to obtain pGL3-roX2prom. Predicted
1.5 kb entry site sequences, centered around the hybridization peaks on the
microarray, were cloned in both orientations into pGL3-roX2prom. Three addi-
tional derivatives of pGL3-Basic were obtained by placing promoter regions
from three autosomal genes: CG2937 (367 bp), CG2960 (668 bp), and
CG7424 (833 bp) upstream of the luciferase gene. DNA fragments with multiple
mutations were obtained by custom gene synthesis (IDT). CES fragments from
pGL3-roX2prom-CES-X constructs were inserted in piB-GFP (Bateman et al.,
2006) by replacing the hs70-GFP cassette.
Fly Genetics and Transgenesis
To obtain msl3 mutant embryos for ChIP-chip experiments, y w; msl3 females
were crossed to y w P{w+, msl3+, cos8-1}/Y; msl3 males (a gift of H. Oh).
Females do not express MSL2; therefore only msl3 mutant male embryos
contributed to the anti-MSL2 ChIP. To generate transgenic flies with a series
of sequences placed within the same genetic environment, we used the
recombination-mediated cassette exchange approach (Bateman et al.,
2006) and the source of phiC31 integrase described in Bischof et al. (2007)
(see further details in the Supplemental Experimental Procedures).Cell 134, 599–609, August 22, 2008 ª2008 Elsevier Inc. 607
To assay for MSL targeting to entry sites in an autosomal context, we used
the H83M2-6I, msl3 background where MSL2 is constitutively expressed from
the hs83 promoter (Kelley et al., 1995; Lyman et al., 1997). CES-X; H83M2-6I,
msl3 females were crossed to MSL3-TAP; msl3 males (Alekseyenko et al.,
2006). Analysis of dosage compensation targeting in embryos under condi-
tions of wild-type, male-specific MSL2 expression was performed using chro-
matin isolated from mixed sex embryos of the following genotype: y w;
CES5C2-6/ MSL3-TAP; msl3.
Dual Luciferase Reporter Assay
Luciferase reporter assays were conducted by cotransfecting SL2 cells with
dsRNA and Firefly and Renilla luciferase plasmids in a 96-well plate (Dual
glo, Promega). Calculations were performed by normalization of Firefly lucifer-
ase units to Renilla luciferase units and determination of standard deviation
among four replicates (see further details in the Supplemental Experimental
Procedures).
Chromatin IP
Embryo ChIP to Initially Identify CES
msl3 mutant embryos (1 g) were collected for chromatin preparation as de-
scribed in Alekseyenko et al. (2006). Immunoprecipitation was performed
with anti-MSL2 antibody, as in Larschan et al. (2007). Details on the small-
scale and large-scale ChIP are provided in the Supplemental Experimental
Procedures.
ChIP-chip and ChIP-seq Data Analysis
Immunoprecipitated DNA was isolated, amplified, and hybridized to Nimble-
Gen tiling arrays as in Alekseyenko et al. (2006). We performed two replicates
for each type of ChIP-chip experiment. For each array, we identified and cor-
rected dye-bias for the log-ratios between ChIP and input using a normalization
method that has been modified for ChIP-chip (for more details see the Supple-
mental Experimental Procedures). For ChIP-seq, the sequenced fragments
were aligned against dm1 genome assembly. Tags with a unique alignment
were accepted if the length was over 20 bp without mismatches, over 26 bp
with one mismatch, over 29 bp with two mismatches, and 30 bp with three
mismatches. This resulted in 2.9M mapped tags for the ChIP run and 1.1M
mapped tags for the input run. Further details can be found in the Supplemen-
tal Experimental Procedures.
ChIP DNA Sample Prep for Solexa/Illumina
Immunoprecipitated DNA from Clone 8 cells was isolated as in Alekseyenko
et al. (2006). DNA amplification was performed using the Illumina Sample
Prep Kit with minor modifications. One microliter adaptor oligo mix was
used per 100 ng ChIP DNA. The ligation mix was first amplified as detailed
in the protocol and then the PCR products (3–8 mg) were gel-fractionated. Pu-
rified DNA was run on the Solexa Genome Analyzer. A detailed protocol for
Solexa sample preparation is available in the Supplemental Experimental
Procedures.
Immunocytochemistry
Polytene chromosomes were isolated from female y w; CES-X; H83M2-6I,
msl3 larvae and processed for immunostaining as described in Larschan
et al. (2007).
Real-Time PCR
Quantitation of immunoprecipitated DNA was performed using real-time PCR
as described in Larschan et al. (2007). Primer sequences used are in Table S4.
ACCESSION NUMBERS
ChIP-chip and ChIP-seq data in this manuscript have been submitted to NCBI
GEO public repository with the accession number GSE11485.
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Supplemental Data include Supplemental Experimental Procedures, six fig-
ures, and four tables and can be found with this article online at http://www.
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